Pricing authority caps rates of key diabetes drugs
India's drug pricing authority has brought two key anti-diabetic drugs - Sitagliptin-Metformin combination and Linagliptin-Metformin combination - under price control. The two anti-diabetic drugs are among the 45 drug formulations whose…